Cargando…

COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Detalles Bibliográficos
Autores principales:	Milojkovic, Dragana, Reynolds, Catherine J., Sandoval, Diana Mūnoz, Pieper, Franziska P., Liu, Siyi, Pade, Corinna, Gibbons, Joseph M., McKnight, Áine, Loaiza, Sandra, Palanicawander, Renuka, Innes, Andrew J., Claudiani, Simone, Apperley, Jane F., Altmann, Daniel M., Boyton, Rosemary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758679/ https://www.ncbi.nlm.nih.gov/pubmed/36528708 http://dx.doi.org/10.1038/s41375-022-01787-8

Ejemplares similares

Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia
por: Claudiani, Simone, et al.
Publicado: (2020)

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
por: May, Philippa C., et al.
Publicado: (2023)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
por: Cook, Lucy B., et al.
Publicado: (2022)

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia
por: Claudiani, Simone, et al.
Publicado: (2019)

Curbside particulate matter and susceptibility to SARS–CoV-2 infection
por: Miyashita, Lisa, et al.
Publicado: (2023)

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly, et al.
Publicado: (2013)

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
por: Usai, Carla, et al.
Publicado: (2022)

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
por: Doykov, Ivan, et al.
Publicado: (2022)

Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors
por: Nteliopoulos, Georgios, et al.
Publicado: (2019)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly M, et al.
Publicado: (2014)

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
por: Manisty, Charlotte, et al.
Publicado: (2021)

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
por: Reynolds, Catherine J., et al.
Publicado: (2021)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands
por: Claudiani, Simone, et al.
Publicado: (2022)

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
por: Astbury, Stuart, et al.
Publicado: (2022)

Boosting in the age of Omicron
por: Sigal, Alex
Publicado: (2023)

Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
por: Jolliffe, David A., et al.
Publicado: (2022)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

What policy makers need to know about COVID-19 protective immunity
por: Altmann, Daniel M, et al.
Publicado: (2020)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
por: Manisty, Charlotte, et al.
Publicado: (2021)

Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
por: Chandran, Aneesh, et al.
Publicado: (2022)

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
por: Milighetti, Martina, et al.
Publicado: (2023)

The role of ibrutinib in COVID-19 hyperinflammation: A case report
por: Maynard, Suzanne, et al.
Publicado: (2021)

A whole genome screen for HIV restriction factors
por: Liu, Li, et al.
Publicado: (2011)

Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis
por: Claudiani, Simone, et al.
Publicado: (2021)

The ins and outs of HIV restriction
por: McKnight, Áine
Publicado: (2013)

Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Innes, Andrew J., et al.
Publicado: (2021)

Omicron’s message on vaccines: Boosting begets breadth
por: Wesemann, Duane R.
Publicado: (2022)

The UK SPIRIT 1 trial in newly-diagnosed chronic myeloid leukaemia (CML)
por: Gallipoli, Paolo, et al.
Publicado: (2022)

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
por: McDonald, Ian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68ov785f9qbb1n1ldre0dohbi6